Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

All articles

From Data to Impact - How industrial companies create real added value with AI

Solve production problems faster and increase efficiency with a clear data strategy and targeted use of AI

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Article

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Article

From Data to Impact - How industrial companies create real added value with AI

Solve production problems faster and increase efficiency with a clear data strategy and targeted use of AI

Article

Addressing Challenges and Opportunities in Medical Writing Using AI

An interview with Dr. Richardus Vonk, Independent Advisor and Dr. Bertram Weiss, VP Health Vertical at Merantix Momentum.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.